IFNG and myeloid sarcoma: This study aimed to examine the plasma level of IFN-γ and plasma relative expression levels of hsa-miR-24-3p and hsa-miR-181 d-3p, and distribution of the IFNG rs2069727 T/C variation which are thought to influence IFN-γ levels, in terms of their contributions to MS risk and disability scores in treatment-naïve RRMS patients as well as in those receiving GA therapy.